What history should be obtained and physical examination performed in a patient being evaluated for antiphospholipid syndrome with both thrombotic and autoimmune manifestations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

History and Physical Examination for Antiphospholipid Syndrome Evaluation

In a patient being evaluated for antiphospholipid syndrome (APS) with both thrombotic and autoimmune manifestations, obtain a detailed history focusing on thrombotic events, pregnancy complications, autoimmune disease symptoms, and perform a targeted physical examination looking for bleeding manifestations, organomegaly, and signs of systemic autoimmune disease.

Essential History Components

Thrombotic History

  • Venous thromboembolism: Document any history of deep vein thrombosis or pulmonary embolism, including age at first event, location, and whether provoked or unprovoked 1
  • Arterial thrombosis: Ask specifically about stroke, transient ischemic attacks, myocardial infarction, and peripheral arterial occlusions 2, 1
  • Unusual site thromboses: Inquire about cerebral venous sinus thrombosis, portal vein thrombosis, splanchnic vein thrombosis, or retinal artery/vein occlusions 2
  • Recurrence pattern: Number of events, timing, and relationship to anticoagulation 3

Obstetric History (for women)

  • Pregnancy losses: Document timing (early vs. late), number of losses, and whether associated with preeclampsia or placental insufficiency 4
  • Preeclampsia: Specifically ask about early-onset (<34 weeks) or severe preeclampsia 4
  • Placental insufficiency: History of fetal growth restriction, oligohydramnios, or abnormal Doppler studies 4
  • Premature births: Induced prematurity due to preeclampsia or placental insufficiency 4

Autoimmune Disease History

  • Systemic lupus erythematosus (SLE): Ask about malar rash, photosensitivity, oral ulcers, arthritis, serositis, renal disease 5
  • Other autoimmune conditions: Inquire about rheumatoid arthritis, Sjögren's syndrome, autoimmune thyroid disease, or other immunodeficiency disorders 5
  • Family history: Document family history of autoimmune diseases or thrombotic events 1, 6

Hematologic Manifestations

  • Thrombocytopenia: History of low platelet counts, bleeding episodes, or easy bruising 5, 7
  • Hemolytic anemia: Ask about jaundice, dark urine, or known hemolysis 7

Neurologic Symptoms

  • Cognitive dysfunction: Memory problems, difficulty concentrating 7
  • Movement disorders: Chorea or other involuntary movements 7
  • Migraine: Pattern, frequency, and associated symptoms 7
  • Seizures: Type and frequency 7
  • Transverse myelitis: Weakness, sensory changes, or bowel/bladder dysfunction 7

Cardiovascular History

  • Cardiac valve disease: History of murmurs, valve thickening, or vegetations 7
  • Atrial fibrillation: Document rhythm abnormalities that could be embolic sources 1
  • Myocardial infarction: Age at event, particularly if young (<50 years) 1

Medication and Exposure History

  • Anticoagulation: Current or past use, including warfarin, heparin, or direct oral anticoagulants 8
  • Hormonal contraceptives: Oral contraceptives, patches, or rings 3
  • Estrogen replacement therapy: Current or past use 3
  • Other medications: Particularly those associated with drug-induced lupus or thrombocytopenia 5

Infectious Disease History

  • HIV status: Test regardless of risk factors, as HIV-associated thrombocytopenia mimics APS 5
  • Hepatitis C: Can present with thrombocytopenia and autoimmune features 5
  • Recent infections: Particularly those that might trigger autoimmune phenomena 5

Additional Risk Factors

  • Smoking history: Current or past tobacco use 2, 1
  • Hypertension: Duration and control 2, 1
  • Diabetes mellitus: Type and duration 2, 1
  • Hyperlipidemia: Known dyslipidemia or treatment 2, 1
  • Malignancy: Current or past cancer, particularly lymphoproliferative disorders 5

Targeted Physical Examination

General Appearance

  • Constitutional symptoms: Fever, weight loss, or cachexia suggesting underlying systemic disease 5

Skin Examination

  • Livedo reticularis: Net-like purplish discoloration, particularly on extremities 7, 6
  • Bleeding manifestations: Petechiae, purpura, or ecchymoses 5
  • Lupus-specific findings: Malar rash, discoid lesions, photosensitive rashes 5
  • Skin necrosis: Areas of tissue necrosis or ulceration 7

Cardiovascular Examination

  • Cardiac auscultation: Listen for murmurs suggesting valvular disease 7
  • Peripheral pulses: Assess for arterial insufficiency 1
  • Blood pressure: Measure in both arms 2

Abdominal Examination

  • Hepatomegaly: Liver enlargement suggests alternative diagnosis or secondary APS 5
  • Splenomegaly: Mild splenomegaly may occur in younger patients, but moderate-to-massive splenomegaly suggests lymphoproliferative disease or other pathology 5

Lymph Node Examination

  • Lymphadenopathy: Generalized or localized enlargement suggests lymphoproliferative disorder or infection rather than primary APS 5

Neurologic Examination

  • Cognitive assessment: Brief mental status evaluation 7
  • Cranial nerves: Complete examination, particularly for visual field defects or diplopia 2
  • Motor and sensory function: Assess for focal deficits suggesting stroke or myelitis 7
  • Movement disorders: Observe for chorea or other involuntary movements 7

Musculoskeletal Examination

  • Joint examination: Assess for synovitis suggesting SLE or other connective tissue disease 5

Critical Pitfalls to Avoid

  1. Do not dismiss isolated IgM antibodies in obstetric APS: While less significant in thrombotic APS, isolated IgM anticardiolipin or anti-β2-glycoprotein-I antibodies are more frequent and clinically relevant in obstetric APS 9, 4

  2. Recognize that normal physical examination does not exclude APS: Aside from bleeding manifestations in thrombocytopenic patients, the physical examination may be entirely normal in primary APS 5

  3. Moderate-to-massive splenomegaly excludes primary APS: This finding mandates investigation for lymphoproliferative disorders, chronic infections (HIV, hepatitis C), or other systemic diseases 5

  4. Constitutional symptoms require alternative diagnosis consideration: Fever, significant weight loss, or night sweats are not features of primary APS and suggest infection, malignancy, or other autoimmune disease 5

  5. Young patients with thrombosis warrant comprehensive APS evaluation: Any arterial thrombosis in patients under 50 years or venous thrombosis under 45 years should prompt APS investigation 2, 1

  6. Pregnancy history must include placental complications: In the 2023 ACR/EULAR criteria, isolated fetal death without preeclampsia or placental insufficiency has minimal diagnostic significance 4

References

Research

A review of antiphospholipid antibody syndrome.

Journal of the American Academy of Nurse Practitioners, 2001

Research

Diagnosis and management of patients with the antiphospholipid syndrome.

Journal of thrombosis and thrombolysis, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.